Skip to main content

Achieve Life Sciences Inc(ACHV-Q)

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Achieve Life Sciences Announces Participation in February Investor Conferences

Globe Newswire - Wed Feb 2, 2022

SEATTLE and VANCOUVER, British Columbia, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it will be participating in the Winter Wonderland Best Ideas Virtual Investor Conference and Aegis Virtual Conference during February 2022. 


Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.